content/01.introduction.md:4:BRAF
content/01.introduction.md:4:BRAF
content/01.introduction.md:4:BRAF
content/01.introduction.md:4:fide
content/01.introduction.md:4:MAPK
content/01.introduction.md:4:tumorigenesis
content/01.introduction.md:6:adenocarcinomas
content/01.introduction.md:6:BRAF
content/01.introduction.md:6:dedifferentiation
content/01.introduction.md:6:MAPK
content/01.introduction.md:6:MAPK
content/01.introduction.md:6:phenotypes
content/01.introduction.md:6:transcriptomic
content/01.introduction.md:6:tumorigenesis
content/01.introduction.md:8:adenocarcinomas
content/01.introduction.md:8:BRAF
content/01.introduction.md:8:MAPK
content/01.introduction.md:8:transcriptional
content/01.introduction.md:8:transcriptional
content/01.introduction.md:8:transcriptomes
content/01.introduction.md:10:BRAF
content/01.introduction.md:10:transcriptional
content/01.introduction.md:16:NSCLC
content/01.introduction.md:18:adenocarcinomas
content/01.introduction.md:18:alveoli
content/01.introduction.md:18:BRAF
content/01.introduction.md:18:EGFR
content/01.introduction.md:18:genomic
content/01.introduction.md:18:histological
content/01.introduction.md:18:histological
content/01.introduction.md:18:KRAS
content/01.introduction.md:18:MAPK
content/01.introduction.md:18:NSCLC
content/01.introduction.md:18:NSCLC
content/01.introduction.md:18:SCLC
content/01.introduction.md:18:subtype
content/01.introduction.md:22:ALK
content/01.introduction.md:22:autophagy
content/01.introduction.md:22:BRAF
content/01.introduction.md:22:Carboplatin
content/01.introduction.md:22:chemotherapeutics
content/01.introduction.md:22:Cisplatin
content/01.introduction.md:22:EGFR
content/01.introduction.md:22:immunotherapy
content/01.introduction.md:22:immunotherapy
content/01.introduction.md:22:MEK
content/01.introduction.md:22:Paclitaxel
content/01.introduction.md:22:Pemetrexed
content/01.introduction.md:22:ROS
content/01.introduction.md:22:TRK
content/01.introduction.md:24:ARAF
content/01.introduction.md:24:BRAF
content/01.introduction.md:24:BRAF
content/01.introduction.md:24:BRAF
content/01.introduction.md:24:constitutively
content/01.introduction.md:24:CRAF
content/01.introduction.md:24:EGF
content/01.introduction.md:24:EGF
content/01.introduction.md:24:glutamic
content/01.introduction.md:24:GTP
content/01.introduction.md:24:GTP
content/01.introduction.md:24:GTP
content/01.introduction.md:24:GTP
content/01.introduction.md:24:kinases
content/01.introduction.md:24:kinases
content/01.introduction.md:24:kinases
content/01.introduction.md:24:Kinases
content/01.introduction.md:24:ligand
content/01.introduction.md:24:ligand
content/01.introduction.md:24:ligands
content/01.introduction.md:24:MAPK
content/01.introduction.md:24:MAPK
content/01.introduction.md:24:MAPK
content/01.introduction.md:24:mitogens
content/01.introduction.md:24:NGF
content/01.introduction.md:24:oncogenic
content/01.introduction.md:24:oncogenic
content/01.introduction.md:24:phosphorylates
content/01.introduction.md:24:phosphorylates
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RAS
content/01.introduction.md:24:RTKs
content/01.introduction.md:24:RTKs
content/01.introduction.md:24:transcriptional
content/01.introduction.md:24:Tyrosine
content/01.introduction.md:24:valine
content/01.introduction.md:26:autophagy
content/01.introduction.md:26:BRAF
content/01.introduction.md:26:BRAF
content/01.introduction.md:26:BRAF
content/01.introduction.md:26:Dabrafenib
content/01.introduction.md:26:kinases
content/01.introduction.md:26:MAPK
content/01.introduction.md:26:MEK
content/01.introduction.md:26:MEK
content/01.introduction.md:26:preclinical
content/01.introduction.md:26:Trametinib
content/01.introduction.md:29:proto
content/01.introduction.md:31:GEMMs
content/01.introduction.md:31:latencies
content/01.introduction.md:31:MNU
content/01.introduction.md:31:penetrance
content/01.introduction.md:33:Cre
content/01.introduction.md:33:Cre
content/01.introduction.md:33:doxycycline
content/01.introduction.md:33:inducible
content/01.introduction.md:33:KRAS
content/01.introduction.md:33:LoxP
content/01.introduction.md:33:LoxP
content/01.introduction.md:33:LoxP
content/01.introduction.md:33:polyadenylation
content/01.introduction.md:33:recombinase
content/01.introduction.md:33:transgenes
content/01.introduction.md:35:BRAF
content/01.introduction.md:35:preclinical
content/01.introduction.md:35:transcriptional
content/01.introduction.md:37:adenocarcinomas
content/01.introduction.md:37:BRAF
content/01.introduction.md:37:EGFR
content/01.introduction.md:37:GEMMs
content/01.introduction.md:37:KRAS
content/01.introduction.md:37:MAPK
content/01.introduction.md:39:BRAF
content/01.introduction.md:39:BRAF
content/01.introduction.md:39:BRAF
content/01.introduction.md:39:BRAF
content/01.introduction.md:39:CAAX
content/01.introduction.md:39:cDNA
content/01.introduction.md:39:Cre
content/01.introduction.md:39:Cre
content/01.introduction.md:39:fluorophore
content/01.introduction.md:39:LoxP
content/01.introduction.md:39:LoxP
content/01.introduction.md:39:oncoprotein
content/01.introduction.md:39:oncoprotein
content/01.introduction.md:39:TdTomato
content/01.introduction.md:41:adenomas
content/01.introduction.md:41:BRAF
content/01.introduction.md:41:BRAF
content/01.introduction.md:41:BRAF
content/01.introduction.md:41:BRAF
content/01.introduction.md:41:Hanahan
content/01.introduction.md:41:MAPK
content/01.introduction.md:41:oncogenic
content/01.introduction.md:41:pneumocytes
content/01.introduction.md:41:proto
content/01.introduction.md:41:Surfactant
content/01.introduction.md:41:Tumorigenesis
content/01.introduction.md:41:WNT
content/01.introduction.md:44:egfr
content/01.introduction.md:44:erk
content/01.introduction.md:44:mek
content/01.introduction.md:44:ras
content/01.introduction.md:46:luad
content/01.introduction.md:46:tumorigenesis
content/01.introduction.md:48:BRAF
content/01.introduction.md:48:gemms
content/01.introduction.md:52:wnt
content/01.introduction.md:58:antigene
content/01.introduction.md:58:decameric
content/01.introduction.md:58:oligomerization
content/01.introduction.md:58:tetramerization
content/01.introduction.md:58:transactivation
content/01.introduction.md:58:transactivation
content/01.introduction.md:58:transcriptional
content/01.introduction.md:58:transcriptional
content/01.introduction.md:58:transcriptional
content/01.introduction.md:60:Fraumeni
content/01.introduction.md:60:leukemias
content/01.introduction.md:64:phenotypes
content/01.introduction.md:64:stressor
content/01.introduction.md:66:cDNA
content/01.introduction.md:66:ectopic
content/01.introduction.md:66:misclassification
content/01.introduction.md:66:RAS
content/01.introduction.md:68:hemizygosity
content/01.introduction.md:68:hotspot
content/01.introduction.md:68:hotspots
content/01.introduction.md:68:tetramer
content/01.introduction.md:68:transcriptional
content/01.introduction.md:70:chemoresistance
content/01.introduction.md:70:Fraumeni
content/01.introduction.md:70:Fraumeni
content/01.introduction.md:70:GOF
content/01.introduction.md:70:GOF
content/01.introduction.md:70:LOF
content/01.introduction.md:70:LOF
content/01.introduction.md:70:missense
content/01.introduction.md:70:missense
content/01.introduction.md:70:tumorigenic
content/01.introduction.md:72:Catenin
content/01.introduction.md:72:CREB
content/01.introduction.md:72:GOF
content/01.introduction.md:72:KRAS
content/02.tubaseq.md:5:adenocarcinomas
content/02.tubaseq.md:5:adenocarcinomas
content/02.tubaseq.md:5:BRAF
content/02.tubaseq.md:5:BRAF
content/02.tubaseq.md:5:BRAF
content/02.tubaseq.md:5:CRISPR
content/02.tubaseq.md:5:EGFR
content/02.tubaseq.md:5:ERK
content/02.tubaseq.md:5:histone
content/02.tubaseq.md:5:lysine
content/02.tubaseq.md:5:MEK
content/02.tubaseq.md:5:methyltransferase
content/02.tubaseq.md:5:oncogenicity
content/02.tubaseq.md:5:pre
content/02.tubaseq.md:5:RAS
content/02.tubaseq.md:5:RNAs
content/02.tubaseq.md:5:syngenetic
content/02.tubaseq.md:5:tumorigenesis
content/02.tubaseq.md:10:dabrafenib
content/02.tubaseq.md:10:trametinib
content/02.tubaseq.md:11:BRAF
content/02.tubaseq.md:11:BRAF
content/02.tubaseq.md:11:differentially
content/02.tubaseq.md:12:BRAF
content/02.tubaseq.md:12:BRAF
content/02.tubaseq.md:12:BRAF
content/02.tubaseq.md:12:colorectal
content/02.tubaseq.md:13:GEMMs
content/02.tubaseq.md:13:pre
content/02.tubaseq.md:15:Genomic
content/02.tubaseq.md:16:histological
content/02.tubaseq.md:17:tumorigenesis
content/02.tubaseq.md:22:bona
content/02.tubaseq.md:22:fide
content/02.tubaseq.md:22:GEMMs
content/02.tubaseq.md:23:GEMMs
content/02.tubaseq.md:23:scalable
content/02.tubaseq.md:23:suboptimal
content/02.tubaseq.md:25:histological
content/02.tubaseq.md:25:IHC
content/02.tubaseq.md:25:immunohistochemistry
content/02.tubaseq.md:28:mor
content/02.tubaseq.md:28:rcode
content/02.tubaseq.md:28:uencing
content/02.tubaseq.md:28:Winslow
content/02.tubaseq.md:29:barcoded
content/02.tubaseq.md:29:Cre
content/02.tubaseq.md:29:Cre
content/02.tubaseq.md:29:lentiviral
content/02.tubaseq.md:29:recombinase
content/02.tubaseq.md:34:BRAF
content/02.tubaseq.md:34:tumorigenesis
content/02.tubaseq.md:35:adenoma
content/02.tubaseq.md:36:BRAF
content/02.tubaseq.md:36:stromal
content/02.tubaseq.md:37:BRAF
content/02.tubaseq.md:37:CRISPR
content/02.tubaseq.md:40:Adenoviral
content/02.tubaseq.md:40:GEMMs
content/02.tubaseq.md:40:lentiviral
content/02.tubaseq.md:40:numerosity
content/02.tubaseq.md:40:titrated
content/02.tubaseq.md:41:adenoviruses
content/02.tubaseq.md:41:barcode
content/02.tubaseq.md:41:lentiviral
content/02.tubaseq.md:42:CRISPR
content/02.tubaseq.md:42:lentiviruses
content/02.tubaseq.md:42:oncogenic
content/02.tubaseq.md:43:BRAF
content/02.tubaseq.md:43:LSL
content/02.tubaseq.md:44:barcoded
content/02.tubaseq.md:44:BRAF
content/02.tubaseq.md:44:BRAF
content/02.tubaseq.md:44:Cre
content/02.tubaseq.md:44:lentiviral
content/02.tubaseq.md:44:plasmids
content/02.tubaseq.md:44:recombinase
content/02.tubaseq.md:44:sgRNA
content/02.tubaseq.md:44:tumorigenesis
content/02.tubaseq.md:45:barcoded
content/02.tubaseq.md:45:lentiviral
content/02.tubaseq.md:45:lentiviruses
content/02.tubaseq.md:47:barcode
content/02.tubaseq.md:47:genomic
content/02.tubaseq.md:47:titer
content/02.tubaseq.md:47:titer
content/02.tubaseq.md:48:barcoded
content/02.tubaseq.md:48:genomic
content/02.tubaseq.md:50:BRAF
content/02.tubaseq.md:51:BRAF
content/02.tubaseq.md:53:histologic
content/02.tubaseq.md:54:BRAF
content/02.tubaseq.md:58:BRAF
content/02.tubaseq.md:59:BRAF
content/02.tubaseq.md:59:catenin
content/02.tubaseq.md:59:tumorigenesis
content/02.tubaseq.md:59:Wnt
content/02.tubaseq.md:60:catenin
content/02.tubaseq.md:61:BRAF
content/02.tubaseq.md:61:tumorigenesis
content/02.tubaseq.md:63:BRAF
content/02.tubaseq.md:63:RNAs
content/02.tubaseq.md:65:immunohistochemistry
content/02.tubaseq.md:65:immunohistochemistry
content/02.tubaseq.md:66:BRAF
content/02.tubaseq.md:66:CRISPR
content/02.tubaseq.md:72:MAPK
content/02.tubaseq.md:73:BRAF
content/02.tubaseq.md:73:Oncogenic
content/02.tubaseq.md:74:BRAF
content/02.tubaseq.md:74:tumorigenesis
content/02.tubaseq.md:75:BRAF
content/02.tubaseq.md:75:GEMMs
content/02.tubaseq.md:75:WNT
content/02.tubaseq.md:77:adenoma
content/02.tubaseq.md:77:BRAF
content/02.tubaseq.md:77:stromal
content/02.tubaseq.md:78:adenomas
content/02.tubaseq.md:78:BRAF
content/02.tubaseq.md:79:adenomas
content/02.tubaseq.md:79:BRAF
content/02.tubaseq.md:79:BRAF
content/02.tubaseq.md:79:doublings
content/02.tubaseq.md:79:doublings
content/02.tubaseq.md:79:histological
content/02.tubaseq.md:80:adenomas
content/02.tubaseq.md:80:BRAF
content/02.tubaseq.md:81:BRAF
content/02.tubaseq.md:82:BRAF
content/02.tubaseq.md:83:fibroblast
content/02.tubaseq.md:83:stromal
content/02.tubaseq.md:83:tumorigenic
content/02.tubaseq.md:84:adenomas
content/02.tubaseq.md:84:BRAF
content/02.tubaseq.md:87:BRAF
content/02.tubaseq.md:87:CRISPR
content/02.tubaseq.md:87:sgRNAs
content/02.tubaseq.md:88:bona
content/02.tubaseq.md:88:fide
content/02.tubaseq.md:89:Wnt
content/02.tubaseq.md:90:BRAF
content/02.tubaseq.md:90:WNT
content/02.tubaseq.md:91:WNT
content/02.tubaseq.md:92:BRAF
content/02.tubaseq.md:95:cBioPortal
content/02.tubaseq.md:96:histone
content/02.tubaseq.md:96:methyltransferase
content/02.tubaseq.md:96:trimethylation
content/02.tubaseq.md:98:mRNA
content/02.tubaseq.md:98:mRNA
content/02.tubaseq.md:98:TCGA
content/02.tubaseq.md:99:BRAF
content/02.tubaseq.md:100:MAPK
content/02.tubaseq.md:101:transcriptional
content/02.tubaseq.md:102:Felder's
content/02.tubaseq.md:102:KRAS
content/02.tubaseq.md:102:tumorigenesis
content/02.tubaseq.md:102:Winslow
content/02.tubaseq.md:103:BRAF
content/02.tubaseq.md:103:KRAS
content/02.tubaseq.md:105:BRAF
content/02.tubaseq.md:105:tumorigenesis
content/02.tubaseq.md:106:KRAS
content/02.tubaseq.md:106:sgRNAs
content/02.tubaseq.md:106:tumorigenic
content/02.tubaseq.md:109:transcriptional
content/02.tubaseq.md:111:CRISPR
content/02.tubaseq.md:111:tumorigenesis
content/02.tubaseq.md:113:adenocarcinomas
content/02.tubaseq.md:113:GEMMs
content/02.tubaseq.md:113:tumorigenesis
content/02.tubaseq.md:114:BRAF
content/02.tubaseq.md:114:tumorigenesis
content/02.tubaseq.md:115:adenocarcinomas
content/02.tubaseq.md:116:BRAF
content/02.tubaseq.md:117:BRAF
content/02.tubaseq.md:121:Cre
content/02.tubaseq.md:121:Lenti
content/02.tubaseq.md:121:LSL
content/02.tubaseq.md:121:LSL
content/02.tubaseq.md:121:LSL
content/02.tubaseq.md:121:LSL
content/02.tubaseq.md:121:plasmid
content/02.tubaseq.md:121:sgRNA
content/02.tubaseq.md:121:supressors
content/02.tubaseq.md:123:Jitter
content/02.tubaseq.md:123:LSL
content/02.tubaseq.md:123:LSL
content/02.tubaseq.md:125:identifed
content/02.tubaseq.md:125:Jitter
content/02.tubaseq.md:125:LSL
content/02.tubaseq.md:125:LSL
content/02.tubaseq.md:125:seperated
content/02.tubaseq.md:125:sgID
content/02.tubaseq.md:127:BRAF
content/02.tubaseq.md:127:Cre
content/02.tubaseq.md:127:Cre
content/02.tubaseq.md:127:Lenti
content/02.tubaseq.md:127:Lenti
content/02.tubaseq.md:127:LSL
content/02.tubaseq.md:127:PFU
content/02.tubaseq.md:129:positivty
content/02.tubaseq.md:129:QuantCenter
content/02.tubaseq.md:129:simuletaneously
content/02.tubaseq.md:131:BRAF
content/02.tubaseq.md:131:dataset
content/02.tubaseq.md:131:mRNA
content/02.tubaseq.md:131:mRNA
content/02.tubaseq.md:131:TGCA
content/03.p53.md:4:adenocarcinomas
content/03.p53.md:4:ARF
content/03.p53.md:4:BRAF
content/03.p53.md:4:BRAF
content/03.p53.md:4:BRAF
content/03.p53.md:4:dedifferentiation
content/03.p53.md:4:GEMMs
content/03.p53.md:4:GEMMs
content/03.p53.md:4:homologs
content/03.p53.md:4:hotspot
content/03.p53.md:4:hotspot
content/03.p53.md:4:MEK
content/03.p53.md:4:missense
content/03.p53.md:4:transcriptome
content/03.p53.md:4:vitro
content/03.p53.md:4:vivo
content/03.p53.md:8:BRAF
content/03.p53.md:8:BRAF
content/03.p53.md:8:BRAF
content/03.p53.md:8:EGFR
content/03.p53.md:8:EGFR
content/03.p53.md:8:EGFR
content/03.p53.md:8:GEMMs
content/03.p53.md:8:histologically
content/03.p53.md:8:KRAS
content/03.p53.md:8:KRAS
content/03.p53.md:8:KRAS
content/03.p53.md:8:LUAD
content/03.p53.md:8:LUAD
content/03.p53.md:8:LUAD
content/03.p53.md:8:MAPK
content/03.p53.md:8:MAPK
content/03.p53.md:8:mutationally
content/03.p53.md:8:oncoproteins
content/03.p53.md:8:pneumocyte
content/03.p53.md:8:Siegel
content/03.p53.md:8:transformative
content/03.p53.md:10:ARF
content/03.p53.md:10:chemoresistance
content/03.p53.md:10:genomic
content/03.p53.md:10:LUAD
content/03.p53.md:10:MDMX
content/03.p53.md:10:phenotypes
content/03.p53.md:10:proliferative
content/03.p53.md:10:TGF
content/03.p53.md:10:transcriptional
content/03.p53.md:10:transcriptional
content/03.p53.md:10:transcriptional
content/03.p53.md:12:BRAF
content/03.p53.md:12:BRAF
content/03.p53.md:12:dysregulation
content/03.p53.md:12:GEMMs
content/03.p53.md:12:homologs
content/03.p53.md:12:hotspots
content/03.p53.md:12:phenotypic
content/03.p53.md:12:tumorigenesis
content/03.p53.md:14:BRAF
content/03.p53.md:14:BRAF
content/03.p53.md:14:hotspot
content/03.p53.md:14:tumorigenesis
content/03.p53.md:14:tumorigenesis
content/03.p53.md:18:BRAF
content/03.p53.md:18:Differentially
content/03.p53.md:18:Tumorigenesis
content/03.p53.md:20:adenovirus
content/03.p53.md:20:BRAF
content/03.p53.md:20:BRAF
content/03.p53.md:20:Cre
content/03.p53.md:20:Cre
content/03.p53.md:20:Cre
content/03.p53.md:20:pfu
content/03.p53.md:20:pneumocytes
content/03.p53.md:20:recombinase
content/03.p53.md:20:Spc
content/03.p53.md:20:surfactant
content/03.p53.md:20:tumorigenic
content/03.p53.md:22:heterozygosity
content/03.p53.md:22:heterozygous
content/03.p53.md:22:LOH
content/03.p53.md:24:homozygous
content/03.p53.md:27:Dedifferentiation
content/03.p53.md:28:dedifferentiated
content/03.p53.md:28:dedifferentiation
content/03.p53.md:28:dedifferentiation
content/03.p53.md:28:dedifferentiation
content/03.p53.md:28:flfl
content/03.p53.md:28:IHC
content/03.p53.md:28:LUAD
content/03.p53.md:28:LUADs
content/03.p53.md:28:SPC
content/03.p53.md:28:SPC
content/03.p53.md:28:transcriptional
content/03.p53.md:30:atypia
content/03.p53.md:30:heterozygous
content/03.p53.md:30:homozygous
content/03.p53.md:30:homozygous
content/03.p53.md:30:Immunohistochemistry
content/03.p53.md:30:immunostaining
content/03.p53.md:30:phosphorylated
content/03.p53.md:30:transcriptional
content/03.p53.md:31:ARF
content/03.p53.md:31:ARF
content/03.p53.md:31:ARF
content/03.p53.md:31:BRAF
content/03.p53.md:31:homozygous
content/03.p53.md:31:homozygous
content/03.p53.md:31:immunofluorescence
content/03.p53.md:33:BRAF
content/03.p53.md:33:MEK
content/03.p53.md:34:BRAF
content/03.p53.md:34:chemotherapies
content/03.p53.md:34:Interstingly
content/03.p53.md:34:MAPK
content/03.p53.md:36:Cre
content/03.p53.md:36:dabrafenib
content/03.p53.md:36:dabrafenib
content/03.p53.md:36:flfl
content/03.p53.md:36:inhibtion
content/03.p53.md:36:MAPK
content/03.p53.md:36:MAPK
content/03.p53.md:36:MAPK
content/03.p53.md:36:phosphorylated
content/03.p53.md:36:proliferative
content/03.p53.md:36:Spc
content/03.p53.md:36:trametinib
content/03.p53.md:38:doxycycline
content/03.p53.md:38:GFP
content/03.p53.md:38:MAPK
content/03.p53.md:38:phenotypes
content/03.p53.md:38:plasmid
content/03.p53.md:38:sucessful
content/03.p53.md:40:BRAF
content/03.p53.md:40:BRAF
content/03.p53.md:40:homolog
content/03.p53.md:40:hotspot
content/03.p53.md:40:lentivirus
content/03.p53.md:40:MEK
content/03.p53.md:40:missense
content/03.p53.md:40:proliferative
content/03.p53.md:43:BRAF
content/03.p53.md:43:transcriptome
content/03.p53.md:44:dedifferentiation
content/03.p53.md:44:MYC
content/03.p53.md:44:phenotypes
content/03.p53.md:44:transcriptional
content/03.p53.md:44:transcriptional
content/03.p53.md:44:transcriptional
content/03.p53.md:44:transcriptomic
content/03.p53.md:44:upregulated
content/03.p53.md:46:PDGFR
content/03.p53.md:47:differentially
content/03.p53.md:47:Imatinib
content/03.p53.md:47:ligand
content/03.p53.md:47:MAPK
content/03.p53.md:47:MAPK
content/03.p53.md:47:PDFRB
content/03.p53.md:47:PDGF
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFR
content/03.p53.md:47:PDGFRB
content/03.p53.md:47:PDGFRB
content/03.p53.md:47:PDGFRB
content/03.p53.md:47:Phospohorylated
content/03.p53.md:47:recepter
content/03.p53.md:47:recombinant
content/03.p53.md:47:upregulated
content/03.p53.md:47:upregulation
content/03.p53.md:52:adenocarcinomas
content/03.p53.md:52:BRAF
content/03.p53.md:52:Cre
content/03.p53.md:52:Cre
content/03.p53.md:52:dedifferentiation
content/03.p53.md:52:hotspot
content/03.p53.md:52:leukemias
content/03.p53.md:52:missense
content/03.p53.md:52:missense
content/03.p53.md:54:BRAF
content/03.p53.md:54:BRAF
content/03.p53.md:54:dabrafenib
content/03.p53.md:54:heterozygosity
content/03.p53.md:54:missense
content/03.p53.md:54:trametinib
content/03.p53.md:54:tumorigenesis
content/03.p53.md:56:adenocarcinomas
content/03.p53.md:56:ARF
content/03.p53.md:56:ARF
content/03.p53.md:56:ARF
content/03.p53.md:56:ARF
content/03.p53.md:56:ARF
content/03.p53.md:56:ARF
content/03.p53.md:56:BRAF
content/03.p53.md:56:BRAF
content/03.p53.md:56:GOF
content/03.p53.md:56:Hyperactivation
content/03.p53.md:56:MAPK
content/03.p53.md:56:MAPK
content/03.p53.md:56:oncogenic
content/03.p53.md:56:PDAC
content/03.p53.md:56:phosphorylated
content/03.p53.md:58:GOF
content/03.p53.md:58:oligomerization
content/03.p53.md:58:transactivation
content/03.p53.md:58:transcriptional
content/03.p53.md:58:transcriptomes
content/03.p53.md:60:BRAF
content/03.p53.md:60:BRAF
content/03.p53.md:60:BRAF
content/03.p53.md:60:chemotherapies
content/03.p53.md:60:GOF
content/03.p53.md:60:Imatinib
content/03.p53.md:60:immunoblotting
content/03.p53.md:60:ligands
content/03.p53.md:60:LSL
content/03.p53.md:60:MEK
content/03.p53.md:60:PDGF
content/03.p53.md:60:PDGFR
content/03.p53.md:60:PDGFR
content/03.p53.md:60:phenotypes
content/03.p53.md:60:transcriptional
content/03.p53.md:62:dabrafenib
content/03.p53.md:62:dedifferentiation
content/03.p53.md:62:pre
content/03.p53.md:62:proliferative
content/03.p53.md:62:trametinib
content/03.p53.md:62:transcriptomes
content/03.p53.md:62:tumorigenic
content/03.p53.md:64:BRAF
content/03.p53.md:64:Cre
content/03.p53.md:64:Cre
content/03.p53.md:64:Cre
content/03.p53.md:64:Priot
content/03.p53.md:64:TdTomato
content/03.p53.md:64:wildtype
content/03.p53.md:66:BRAF
content/03.p53.md:66:Cre
content/03.p53.md:66:Cre
content/03.p53.md:66:Cre
content/03.p53.md:66:differentially
content/03.p53.md:66:histological
content/03.p53.md:66:recombinase
content/03.p53.md:66:Recombinase
content/03.p53.md:66:Recombinase
content/03.p53.md:66:tumorigenesis
content/03.p53.md:70:differentially
content/03.p53.md:70:homozygous
content/03.p53.md:70:Kaplan
content/03.p53.md:70:Kaplan
content/03.p53.md:72:IHC
content/03.p53.md:72:immunostaing
content/03.p53.md:72:Missense
content/03.p53.md:72:SPC
content/03.p53.md:74:ARF
content/03.p53.md:74:ARF
content/03.p53.md:74:atypia
content/03.p53.md:74:immunostaining
content/03.p53.md:74:immunostaining
content/03.p53.md:74:phospho
content/03.p53.md:74:SPC
content/03.p53.md:76:dabrafenib
content/03.p53.md:76:dabrafenib
content/03.p53.md:76:GEMMs
content/03.p53.md:76:MAPK
content/03.p53.md:76:MAPKi
content/03.p53.md:76:timecourse
content/03.p53.md:76:trametinib
content/03.p53.md:79:CytoTox
content/03.p53.md:79:dabrafinib
content/03.p53.md:79:dabrafinib
content/03.p53.md:79:Incucyte
content/03.p53.md:79:MAPKi
content/03.p53.md:79:trametinib
content/03.p53.md:79:trametinib
content/03.p53.md:81:doxycycline
content/03.p53.md:81:Doxycycline
content/03.p53.md:83:dabrafenib
content/03.p53.md:83:ectopic
content/03.p53.md:83:HCC
content/03.p53.md:83:Incucyte
content/03.p53.md:83:MAPKi
content/03.p53.md:83:trametenib
content/03.p53.md:86:Differentially
content/03.p53.md:86:transcriptome
content/03.p53.md:88:differentially
content/03.p53.md:88:differentially
content/03.p53.md:88:differntially
content/03.p53.md:90:GEMM
content/03.p53.md:90:IHC
content/03.p53.md:90:PDGF
content/03.p53.md:90:PDGFRB
content/03.p53.md:90:PDGFRB
content/03.p53.md:90:upregulated
content/03.p53.md:92:Imatinib
content/03.p53.md:92:patway
content/03.p53.md:92:PDGF
content/03.p53.md:92:PDGF
content/03.p53.md:92:PDGF
content/04.singlecell.md:4:adenocarcinomas
content/04.singlecell.md:4:adenocarcinomas
content/04.singlecell.md:4:BRAF
content/04.singlecell.md:4:BRAF
content/04.singlecell.md:4:diffuclt
content/04.singlecell.md:4:genomic
content/04.singlecell.md:4:genotypes
content/04.singlecell.md:4:heterogenity
content/04.singlecell.md:4:heterogenity
content/04.singlecell.md:4:heterogenity
content/04.singlecell.md:4:heterogenity
content/04.singlecell.md:4:histological
content/04.singlecell.md:4:oncoprotein
content/04.singlecell.md:4:seperate
content/04.singlecell.md:4:stereotypically
content/04.singlecell.md:4:thorughout
content/04.singlecell.md:4:transcriptomes
content/04.singlecell.md:4:wheter
content/04.singlecell.md:7:alveoli
content/04.singlecell.md:7:alveoli
content/04.singlecell.md:7:alveoli
content/04.singlecell.md:7:cuboidal
content/04.singlecell.md:7:meshwork
content/04.singlecell.md:7:stereotypic
content/04.singlecell.md:7:surfactant
content/04.singlecell.md:9:adenocarcinomas
content/04.singlecell.md:9:alveoli
content/04.singlecell.md:11:GEMM
content/04.singlecell.md:11:GEMMs
content/04.singlecell.md:11:intra
content/04.singlecell.md:11:pre
content/04.singlecell.md:11:transcriptional
content/04.singlecell.md:11:transcriptomes
content/04.singlecell.md:11:tumoral
content/04.singlecell.md:13:adenocarcinomas
content/04.singlecell.md:13:adenocarcinomas
content/04.singlecell.md:13:adenocarcinomas
content/04.singlecell.md:13:adenocarcinomas
content/04.singlecell.md:13:BRAF
content/04.singlecell.md:13:GEMMs
content/04.singlecell.md:13:GEMMs
content/04.singlecell.md:13:GEMMs
content/04.singlecell.md:13:genotype
content/04.singlecell.md:13:transcriptomes
content/04.singlecell.md:13:tumorigenesis
content/04.singlecell.md:16:BRAF
content/04.singlecell.md:16:ScRNA
content/04.singlecell.md:17:adenoviral
content/04.singlecell.md:17:BRAF
content/04.singlecell.md:17:BRAF
content/04.singlecell.md:17:BRAF
content/04.singlecell.md:17:Cre
content/04.singlecell.md:17:dabrafenib
content/04.singlecell.md:17:dabrafenib
content/04.singlecell.md:17:FACS
content/04.singlecell.md:17:fluorescently
content/04.singlecell.md:17:genotype
content/04.singlecell.md:17:preperation
content/04.singlecell.md:17:Seuratbased
content/04.singlecell.md:17:Spc
content/04.singlecell.md:17:trametinib
content/04.singlecell.md:17:trametinib
content/04.singlecell.md:17:transcriptome
content/04.singlecell.md:19:mesenchymal
content/04.singlecell.md:19:mesenchymal
content/04.singlecell.md:19:positivity
content/04.singlecell.md:19:stromal
content/04.singlecell.md:19:TdTomato
content/04.singlecell.md:21:Reclustering
content/04.singlecell.md:21:TdTomato
content/04.singlecell.md:23:dabrafenib
content/04.singlecell.md:23:Figre
content/04.singlecell.md:23:genotpes
content/04.singlecell.md:23:MAPK
content/04.singlecell.md:23:trametinib
content/04.singlecell.md:23:transcriptional
content/04.singlecell.md:25:genotype
content/04.singlecell.md:25:genotype
content/04.singlecell.md:27:genotypes
content/04.singlecell.md:28:Pre
content/04.singlecell.md:29:pre
content/04.singlecell.md:36:heatmap
content/04.singlecell.md:37:heatmap
content/04.singlecell.md:37:MAPK
content/04.singlecell.md:41:adenocarcinomas
content/04.singlecell.md:41:BRAF
content/04.singlecell.md:41:BRAF
content/04.singlecell.md:41:concomminant
content/04.singlecell.md:41:heterogenity
content/04.singlecell.md:41:MAPK
content/04.singlecell.md:41:MAPK
content/04.singlecell.md:41:mimick
content/04.singlecell.md:41:oncogenic
content/04.singlecell.md:41:scRNA
content/04.singlecell.md:41:theraputic
content/04.singlecell.md:41:transcriptional
content/04.singlecell.md:43:dedifferentiation
content/04.singlecell.md:43:genomic
content/04.singlecell.md:43:genomic
content/04.singlecell.md:43:genotypes
content/04.singlecell.md:43:heterogenity
content/04.singlecell.md:43:KRAS
content/04.singlecell.md:43:pastic
content/04.singlecell.md:43:pre
content/04.singlecell.md:43:previousl
content/04.singlecell.md:43:reporducible
content/04.singlecell.md:43:transcriptional
content/04.singlecell.md:43:tumorigenesis
content/04.singlecell.md:43:Unfortunely
content/04.singlecell.md:45:genomic
content/04.singlecell.md:45:genotype
content/04.singlecell.md:45:genotypes
content/04.singlecell.md:45:missense
content/04.singlecell.md:45:preperation
content/04.singlecell.md:45:scRNA
content/04.singlecell.md:45:similiar
content/04.singlecell.md:45:timecourse
content/04.singlecell.md:45:timepoints
content/04.singlecell.md:45:timepoints
content/04.singlecell.md:45:transcriptional
content/04.singlecell.md:45:transcriptomic
content/04.singlecell.md:46:genotype
content/04.singlecell.md:46:heterogenity
content/04.singlecell.md:46:scRNA
content/04.singlecell.md:46:transcirptional
content/04.singlecell.md:48:genotypes
content/04.singlecell.md:48:homogenous
content/04.singlecell.md:48:intial
content/04.singlecell.md:48:MAPK
content/04.singlecell.md:48:MAPK
content/04.singlecell.md:48:MAPK
content/04.singlecell.md:48:MAPK
content/04.singlecell.md:48:MAPK
content/04.singlecell.md:48:transcriptional
content/04.singlecell.md:48:transcriptional
content/04.singlecell.md:48:transcriptional
content/04.singlecell.md:50:acorss
content/04.singlecell.md:50:BRAF
content/04.singlecell.md:50:BRAF
content/04.singlecell.md:50:genotypes
content/04.singlecell.md:50:genotypes
content/04.singlecell.md:50:seperate
content/04.singlecell.md:50:stereotypic
content/04.singlecell.md:50:timepoints
content/04.singlecell.md:50:transciprtional
content/04.singlecell.md:50:transcriptional
content/04.singlecell.md:50:transcriptomes
content/04.singlecell.md:56:KRAS
content/04.singlecell.md:57:homogenous
content/04.singlecell.md:59:genotypes
content/04.singlecell.md:61:mesenchymal
content/04.singlecell.md:63:BRAF
content/04.singlecell.md:63:transcripional
content/04.singlecell.md:63:tumorigenesis
content/04.singlecell.md:66:Transcriptional
content/04.singlecell.md:68:BRAV
content/04.singlecell.md:68:transcriptional
content/04.singlecell.md:68:wildtype
content/04.singlecell.md:70:BRAV
content/04.singlecell.md:70:transcriptional
content/04.singlecell.md:70:wildtype
content/04.singlecell.md:72:Genotpye
content/05.Methods.md:2:Adeno
content/05.Methods.md:2:Biosafety
content/05.Methods.md:2:Biosafety
content/05.Methods.md:2:BRAF
content/05.Methods.md:2:CRE
content/05.Methods.md:2:genotyping
content/05.Methods.md:2:genotyping
content/05.Methods.md:2:Gigi
content/05.Methods.md:2:Lozano
content/05.Methods.md:2:SPC
content/05.Methods.md:4:amlifying
content/05.Methods.md:4:AMPure
content/05.Methods.md:4:approximetley
content/05.Methods.md:4:barcode
content/05.Methods.md:4:Barcoded
content/05.Methods.md:4:Cre
content/05.Methods.md:4:CRISPR
content/05.Methods.md:4:DMEM
content/05.Methods.md:4:FBS
content/05.Methods.md:4:genomic
content/05.Methods.md:4:Genomic
content/05.Methods.md:4:HEK
content/05.Methods.md:4:intratracheal
content/05.Methods.md:4:intubation
content/05.Methods.md:4:lentiiral
content/05.Methods.md:4:lentiviral
content/05.Methods.md:4:lentiviral
content/05.Methods.md:4:Lentiviral
content/05.Methods.md:4:Lentivirus
content/05.Methods.md:4:LSL
content/05.Methods.md:4:ofmale
content/05.Methods.md:4:PCR
content/05.Methods.md:4:proteinase
content/05.Methods.md:4:Qubit
content/05.Methods.md:4:sgRNA
content/05.Methods.md:4:Suquencing
content/05.Methods.md:4:titered
content/05.Methods.md:4:Winslow
content/05.Methods.md:4:Winslow
content/05.Methods.md:6:BRAF
content/05.Methods.md:6:Collagenase
content/05.Methods.md:6:cytometry
content/05.Methods.md:6:dispase
content/05.Methods.md:6:DMEM
content/05.Methods.md:6:elastase
content/05.Methods.md:6:lysis
content/05.Methods.md:6:passaged
content/05.Methods.md:6:resuspended
content/05.Methods.md:6:resuspended
content/05.Methods.md:6:RPMI
content/05.Methods.md:6:stromal
content/05.Methods.md:6:tdTomato
content/05.Methods.md:6:trypsinization
content/05.Methods.md:8:DMEM
content/05.Methods.md:8:FBS
content/05.Methods.md:8:HCC
content/05.Methods.md:8:mycoplasma
content/05.Methods.md:10:BCA
content/05.Methods.md:10:clX
content/05.Methods.md:10:Immunoblotting
content/05.Methods.md:10:Licor
content/05.Methods.md:10:lysate
content/05.Methods.md:10:lysed
content/05.Methods.md:10:microgram
content/05.Methods.md:10:phosphatase
content/05.Methods.md:10:protease
content/05.Methods.md:10:PVDF
content/05.Methods.md:10:RIPA
content/05.Methods.md:10:SDS
content/05.Methods.md:10:supernatant
content/05.Methods.md:10:tris
content/05.Methods.md:12:fastq
content/05.Methods.md:12:FastQC
content/05.Methods.md:12:FeatureCounts
content/05.Methods.md:12:Galazy
content/05.Methods.md:12:Illumina
content/05.Methods.md:12:mRNA
content/05.Methods.md:12:MultiQC
content/05.Methods.md:12:Qiagen
content/05.Methods.md:12:TruSeq
content/05.Methods.md:12:UDI
content/05.Methods.md:14:ARF
content/05.Methods.md:14:Immunofluoresence
content/05.Methods.md:14:Immunohistochemistry
content/05.Methods.md:14:Immunohistochemistry
content/05.Methods.md:14:phospho
content/05.Methods.md:14:SPC
content/05.Methods.md:17:Caseviewer
content/05.Methods.md:17:eosin
content/05.Methods.md:17:Hematoxylin
content/05.Methods.md:17:Histech
content/05.Methods.md:17:Histech
content/05.Methods.md:17:Histech
content/05.Methods.md:17:IHC
content/05.Methods.md:17:Pannoramic
content/05.Methods.md:17:QuantCenter
content/05.Methods.md:17:QuantCenter
content/05.Methods.md:17:Thermo
content/05.Methods.md:19:BD
content/05.Methods.md:19:Cre
content/05.Methods.md:19:cytometer
content/05.Methods.md:19:dabrafenib
content/05.Methods.md:19:HCI
content/05.Methods.md:19:previusly
content/05.Methods.md:19:Spc
content/05.Methods.md:19:trametenib
content/05.Methods.md:23:Actin
content/05.Methods.md:23:wb
content/05.Methods.md:24:IHC
content/05.Methods.md:24:Phospho
content/05.Methods.md:24:wb
content/05.Methods.md:25:wb
content/05.Methods.md:26:IHC
content/05.Methods.md:26:Leica
content/05.Methods.md:26:wb
content/05.Methods.md:27:Abcam
content/05.Methods.md:27:IHC
content/05.Methods.md:28:IHC
content/05.Methods.md:28:Millipore
content/05.Methods.md:28:SPC
content/05.Methods.md:29:IHC
content/05.Methods.md:30:ARF
content/05.Methods.md:30:Sherr
content/05.Methods.md:31:ATCC
content/05.Methods.md:31:CRL
content/05.Methods.md:32:Bivona
content/05.Methods.md:32:HCC
content/05.Methods.md:33:Addgene
content/05.Methods.md:33:Recombinant
content/05.Methods.md:34:Addgene
content/05.Methods.md:34:Recombinant
content/05.Methods.md:35:Addgene
content/05.Methods.md:35:Recombinant
content/05.Methods.md:36:dabrafenib
content/05.Methods.md:36:Selleck
content/05.Methods.md:37:Plexxikon
content/05.Methods.md:38:Selleck
content/05.Methods.md:38:trametinib
content/05.Methods.md:39:Collagenase
content/05.Methods.md:39:Thermo
content/05.Methods.md:40:Dispase
content/05.Methods.md:41:Biochem
content/05.Methods.md:41:Elastase
content/05.Methods.md:41:Worthington
content/05.Methods.md:42:Cre
content/05.Methods.md:42:VVC
content/06.future.md:4:BRAF
content/06.future.md:4:BRAF
content/06.future.md:4:scRNA
content/06.future.md:4:tumorigenesis
content/06.future.md:6:MAPK
content/06.future.md:6:MAPK
content/06.future.md:6:preclinical
content/06.future.md:8:BRAF
content/06.future.md:8:dedifferentiation
content/06.future.md:8:hyperactivation
content/06.future.md:8:KRAS
content/06.future.md:8:KRAS
content/06.future.md:8:KRAS
content/06.future.md:8:MAPK
content/06.future.md:8:MAPK
content/06.future.md:8:MAPK
content/06.future.md:8:MAPK
content/06.future.md:8:MAPK
content/06.future.md:8:MAPK
content/06.future.md:8:mutationally
content/06.future.md:8:tumorigenesis
content/06.future.md:8:tumorigenesis
content/06.future.md:8:tumorigenesis
content/06.future.md:10:ARF
content/06.future.md:10:MAPK
content/06.future.md:10:MAPK
content/06.future.md:10:MAPK
content/06.future.md:10:oncogenic
content/06.future.md:10:supression
content/06.future.md:10:tumorigenesis
content/06.future.md:10:WNT
content/06.future.md:10:WNT
content/06.future.md:12:aneuploidy
content/06.future.md:12:BRAF
content/06.future.md:12:BRAF
content/06.future.md:12:differentially
content/06.future.md:12:genomic
content/06.future.md:12:hotspot
content/06.future.md:12:isogenic
content/06.future.md:12:MAPK
content/06.future.md:12:missense
content/06.future.md:12:missense
content/06.future.md:12:phenotypic
content/06.future.md:12:transcriptional
content/06.future.md:12:tumorigenesis
content/06.future.md:14:colorectal
content/06.future.md:14:CRISPR
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:ARF
content/06.future.md:16:BRAF
content/06.future.md:16:BRAF
content/06.future.md:16:MAPK
content/06.future.md:16:RNAs
content/06.future.md:16:siRNAs
content/06.future.md:16:tumorigenesis
content/06.future.md:20:MAPK
content/06.future.md:20:MAPK
content/06.future.md:20:occured
content/06.future.md:21:MAPK
content/06.future.md:21:MAPK
content/06.future.md:21:MAPK
content/06.future.md:21:MAPK
content/06.future.md:21:MAPK
content/06.future.md:23:contraindicator
content/06.future.md:23:genomic
content/06.future.md:23:MAPK
content/06.future.md:23:preclinical
content/06.future.md:25:autophagy
content/06.future.md:25:BRAFi
content/06.future.md:25:dabrafenib
content/06.future.md:25:ERKi
content/06.future.md:25:MAPK
content/06.future.md:25:MAPK
content/06.future.md:25:MAPK
content/06.future.md:25:MEKi
content/06.future.md:25:trametinib
content/06.future.md:27:BRAF
content/06.future.md:27:dysregulation
content/06.future.md:27:transcriptional
content/06.future.md:27:transcriptomes
content/06.future.md:27:tumorigenesis
content/06.future.md:27:undescribed
content/06.future.md:29:BRAF
content/06.future.md:29:BRAF
content/06.future.md:29:genomic
content/06.future.md:29:MAPK
content/06.future.md:29:preclinical
content/06.future.md:29:tumorigenesis
content/06.future.md:29:tumorigenesis
